The best way to avoid showers becoming a hidradenitis suppurativa trigger: Stick to a gentle, fragrance-free body wash or an ...

The U.S. Food and Drug Administration has approved UCB's Bimzelx (bimekizumab-bkzx) for the treatment of adults with moderate ...

Cantargia has commenced an expanded segment of the ongoing Phase I trial of its antibody, CAN10, with the first participant ...

The US Food and Drug Administration has approved bimekizumab, a humanized interleukin (IL)-17A and IL-17F antagonist, for the ...

Stress about HS can interfere with your ability to form and enjoy intimate relationships—but it doesn’t have to.

This approval is the fifth overall for bimekizumab (Bimzelyx; UCB Pharma) in the US, and they all have come in the last 13 ...

The drug survival for adalimumab is significantly higher than that of infliximab in pediatric patients with hidradenitis suppurativa (HS), results from a small single-center study showed.

The FDA has approved UCB's Bimzelx for moderate-to-severe hidradenitis suppurativa, offering a new treatment option for this ...

When you live with hidradenitis suppurativa (HS), an inflammatory skin condition that causes painful, recurrent nodules, abscesses, tunnels, and scars under the skin, medications may not be enough.